Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy.

Autor: Di Micco P; UOC Medicina y Urgencia-ASL NAPOLI 2 Nord Ospedale Anna Rizzoli di Lacco Ameno, 34110 Naples, Italy., Salazar VR; Department of Internal Medicine, Hospital Universitario Virgen de Arrixaca, 30627 Murcia, Spain., Capitan CF; Department of Internal Medicine, Hospital Universitario La Paz, 28015 Madrid, Spain., Dentali F; Department of Medicine and Surgery, Insubria University, 21100 Varese, Italy., Cuervo CG; Department of Internal Medicine, Hospital Universitario 12 de Octubre, 28015 Madrid, Spain., Torres JLF; Department of Internal Medicine, Complejo Hospitalario de Jaén, 23160 Jaén, Spain., Porras JA; Department of Internal Medicine, Hospital Universitario Joan XXIII de Tarragona, 43003 Tarragona, Spain., Fidalgo A; Department of Internal Medicine, Hospital Universitario de Salamanca, 37004 Salamanca, Spain., Grandone E; Atherosclerosis and Thrombosis Unit, Casa Sollievo Della Sofferenza, 71121 Foggia, Italy.; Medical and Surgical Sciences Dept., University of Foggia, 71121 Foggia, Italy.; Ob/Gyn Dept., First Moscow State Medical University, 101000 Moscow, Russia., Meseguer ML; Department of Pneumonology, Hospital Universitario Vall d'Hebron, 08016 Barcelona, Spain., Monreal M; Chair for the Study of Thromboembolic Disease, Faculty of Health Sciences, UCAM-Universidad Católica San Antonio de Murcia, 30627 Murcia, Spain., The Riete Investigators

Publikováno v: Life (Basel, Switzerland) [Life (Basel)] 2022 Jul 27; Vol. 12 (8). Date of Electronic Publication: 2022 Jul 27.